Perfil
Donald Handley worked as a Director of Global Regulatory Affairs at Bausch & Lomb, Inc. and as a Director of Regulatory Affairs at Cleveland BioLabs, Inc. Prior to that, he was a Manager of Worldwide Regulatory Affairs at Bristol Myers Squibb Co. and a Senior Manager of Regulatory Affairs at Celltech Medeva.
He received his undergraduate and graduate degrees from The State University of New York and also holds an MBA.
Antiguos cargos conocidos de Donald Handley.
| Empresas | Cargo | Fin |
|---|---|---|
| Celltech Medeva /Anesthetic Business/ | Consejero General | 01/01/2002 |
| BRISTOL-MYERS SQUIBB COMPANY | Consejero General | 01/01/1999 |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Consejero General | - |
| STATERA BIOPHARMA, INC. | Consejero General | - |
Formación de Donald Handley.
| The State University of New York | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Empresas privadas | 3 |
|---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
| Celltech Medeva /Anesthetic Business/ | Health Technology |
- Bolsa de valores
- Insiders
- Donald Handley
